1,258
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Ultrasound-guided laser ablation for local control of neck recurrences of medullary thyroid cancer. A feasibility study

, , , , , , & show all
Pages 480-492 | Received 29 May 2018, Accepted 30 Jul 2018, Published online: 11 Sep 2018

References

  • Wells SA, Jr, Asa SL, Dralle H, et al. American thyroid association guidelines task force on medullary thyroid carcinoma. revised american thyroid association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015;25:567–610.
  • Abraham DT, Low TH, Messina M, et al. Medullary thyroid carcinoma: long-term outcomes of surgical treatment. Ann Surg Oncol. 2011;18:219–225.
  • Kebebew E, Greenspan FS, Clark OH, et al. Extent of disease and practice patterns for medullary thyroid cancer. J Am Coll Surg. 2005;200:890–896.
  • Scollo C, Baudin E, Travagli JP, et al. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. J Clin Endocrinol Metab. 2003;88:2070–2075.
  • NCCN Clinical Practice Guidelines in Oncology (2016) Medullary thyroid carcinoma. https://www.nccn.org/professionals/physician_gls/pdf/thyroid.pdf
  • Konstantinidis A, Stang M, Roman SA, et al. Surgical management of medullary thyroid carcinoma. Updates Surg. 2017;69:151–160.
  • Pacella CM, Bizzarri G, Guglielmi R, et al. Thyroid tissue: US-guided percutaneous interstitial laser ablation-a feasibility study. Radiology. 2000;217:673–677.
  • Pacella CM, Mauri G, Achille G, et al. Outcomes and risk factors for complications of laser ablation for thyroid nodules: a multicenter study on 1531 patients. J Clin Endocrinol Metab. 2015;100:3903–3910.
  • Papini E, Bizzarri G, Bianchini A, et al. Percutaneous ultrasound-guided laser ablation is effective for treating selected nodal metastases in papillary thyroid cancer. J Clin Endocrinol Metab. 2013;98:E92–E97.
  • Mauri G, Cova L, Tondolo T, et al. Percutaneous laser ablation of metastatic lymph nodes in the neck from papillary thyroid carcinoma: preliminary results. J Clin Endocrinol Metab. 2013;98: E1203–E1207.
  • Mauri G, Cova L, Ierace T, et al. Treatment of metastatic lymph nodes in the neck from papillary thyroid carcinoma with percutaneous laser ablation. Cardiovasc Intervent Radiol. 2016;39: 1023–1030.
  • Cibas ES, Ali SZ. NCI Thyroid FNA state of the science conference. The Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol. 2009;132:658–665.
  • American Joint Committee on Cancer. Thyroid–Medullary. In: Rosen JE, Lloyd RV, Brierly JD, et al., editors. AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017: 891.
  • Pacella CM, Bizzarri G, Spiezia S, et al. Thyroid tissue: US-guided percutaneous laser thermal ablation. Radiology. 2004;232: 272–280.
  • Machens A, Dralle H. Benefit-risk balance of reoperation for persistent medullary thyroid cancer. Ann Surg. 2013; 257:751–757.
  • Machens A, Gimm O, Ukkat J, et al. Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysis. Cancer. 2000; 88:1909–1915.
  • Van Heerden JA, Grant CS, Gharib H, et al. Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma. Ann Surg. 1990;212:395–400.
  • Owen RP, Silver CE, Ravikumar TS, et al. Techniques for radiofrequency ablation of head and neck tumors. Arch Otolaryngol Head Neck Surg. 2004;130:52–56.
  • Jeong SY, Baek JH, Choi YJ, et al. Ethanol and thermal ablation for malignant thyroid tumours. Int J Hyperthermia. 2017;33: 938–945.
  • Pacella CM, Mauri G, Cesareo R, et al. A comparison of laser with radiofrequency ablation for the treatment of benign thyroid nodules: a propensity score matching analysis. Int J Hyperthermia. 2017;33:911–919.